These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21744232)

  • 21. Hepatic steatosis assessment with 1H-spectroscopy and chemical shift imaging at 3.0 T before hepatic surgery: reliable enough for making clinical decisions?
    Koelblinger C; Krššák M; Maresch J; Wrba F; Kaczirek K; Gruenberger T; Tamandl D; Ba-Ssalamah A; Berger-Kulemann V; Weber M; Schima W
    Eur J Radiol; 2012 Nov; 81(11):2990-5. PubMed ID: 22770582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis.
    Cowin GJ; Jonsson JR; Bauer JD; Ash S; Ali A; Osland EJ; Purdie DM; Clouston AD; Powell EE; Galloway GJ
    J Magn Reson Imaging; 2008 Oct; 28(4):937-45. PubMed ID: 18821619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
    Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
    Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of liver triglycerides by 1H MR spectroscopy].
    Hájek M; Dezortová M; Wagnerová D; Voska L; Hejlová I; Trunecka P
    Cas Lek Cesk; 2011; 150(1):68-71. PubMed ID: 21404492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy.
    Meisamy S; Hines CD; Hamilton G; Sirlin CB; McKenzie CA; Yu H; Brittain JH; Reeder SB
    Radiology; 2011 Mar; 258(3):767-75. PubMed ID: 21248233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential of electron beam computed tomography for coronary artery calcium screening to evaluate fatty liver: comparison with 1H magnetic resonance spectroscopy in the Dallas Heart Study.
    Matulevicius S; Huff LC; Szczepaniak LS; Ayers CR; Budoff M; McColl R; Khera A; Peshock RM
    J Investig Med; 2011 Jun; 59(5):780-6. PubMed ID: 21441828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined Use of MR Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need for Preoperative Liver Biopsy?
    Yoon JH; Lee JM; Suh KS; Lee KW; Yi NJ; Lee KB; Han JK; Choi BI
    Radiology; 2015 Aug; 276(2):453-64. PubMed ID: 25763828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility based multiparametric quantification of liver disease: Non-invasive evaluation of steatosis and iron overload.
    Uhrig M; Mueller J; Longerich T; Straub BK; Buschle LR; Schlemmer HP; Mueller S; Ziener CH
    Magn Reson Imaging; 2019 Nov; 63():114-122. PubMed ID: 31425813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry.
    Roldan-Valadez E; Favila R; Martínez-López M; Uribe M; Ríos C; Méndez-Sánchez N
    J Hepatol; 2010 Oct; 53(4):732-7. PubMed ID: 20594607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease: quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Zhong L; Chen JJ; Chen J; Li L; Lin ZQ; Wang WJ; Xu JR
    J Dig Dis; 2009 Nov; 10(4):315-20. PubMed ID: 19906112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study.
    Thomas EL; Hamilton G; Patel N; O'Dwyer R; Doré CJ; Goldin RD; Bell JD; Taylor-Robinson SD
    Gut; 2005 Jan; 54(1):122-7. PubMed ID: 15591516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive quantification of hepatic steatosis in rats using 3.0 T 1H-magnetic resonance spectroscopy.
    Marsman HA; van Werven JR; Nederveen AJ; Ten Kate FJ; Heger M; Stoker J; van Gulik TM
    J Magn Reson Imaging; 2010 Jul; 32(1):148-54. PubMed ID: 20578022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.
    Banerjee R; Pavlides M; Tunnicliffe EM; Piechnik SK; Sarania N; Philips R; Collier JD; Booth JC; Schneider JE; Wang LM; Delaney DW; Fleming KA; Robson MD; Barnes E; Neubauer S
    J Hepatol; 2014 Jan; 60(1):69-77. PubMed ID: 24036007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy.
    Machann J; Thamer C; Schnoedt B; Stefan N; Haring HU; Claussen CD; Fritsche A; Schick F
    Magn Reson Med; 2006 Apr; 55(4):913-7. PubMed ID: 16506186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults.
    Tyagi A; Yeganeh O; Levin Y; Hooker JC; Hamilton GC; Wolfson T; Gamst A; Zand AK; Heba E; Loomba R; Schwimmer J; Middleton MS; Sirlin CB
    Abdom Imaging; 2015 Oct; 40(8):3070-7. PubMed ID: 26350282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model.
    van Werven JR; Marsman HA; Nederveen AJ; ten Kate FJ; van Gulik TM; Stoker J
    Magn Reson Imaging; 2012 Jan; 30(1):112-21. PubMed ID: 21940131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy.
    Martín-Rodríguez JL; Arrebola JP; Jiménez-Moleón JJ; Olea N; González-Calvin JL
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):88-94. PubMed ID: 23921844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of hydrogen proton magnetic resonance spectroscopy in the determination of liver triglyceride in patients with fatty liver disease and its influencing factors].
    Qu HJ; Wang L; Jin PH; Gao Q; Zhou JX; Song Y; Wang J; Jiang YM; Gong L; Chen GY; Ding JP; Shi JP
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):858-863. PubMed ID: 29325281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.